To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE1
Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow
- Status
- COMPLETED
- Phase
- PHASE2
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE2
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers in Young Patients With Neuroblastoma
- Status
- COMPLETED
- Phase
- N/A
131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol
- Status
- AVAILABLE
- Phase
- N/A
Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Role of IMP3 Expression in Patients With Neuroblastoma
- Status
- COMPLETED
- Phase
- N/A
Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])
- Status
- COMPLETED
- Phase
- N/A
Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
- Status
- RECRUITING
- Phase
- N/A
Pharmacokinetic Study of Doxorubicin in Children With Cancer
- Status
- COMPLETED
- Phase
- PHASE2